Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens.

AUTOR(ES)

Keydar, I

RESUMO

We have generated a mouse monoclonal antibody (H23) against the retrovirus-like particles (human mammary tumor virus) released in vitro by the human breast adenocarcinoma cell line T47D. This antibody reacts specifically with a glycoprotein with an apparent molecular mass of 68 kDa (gp68) that is detected in the growth medium of T47D cells as well as in pleural effusion fluids from breast adenocarcinoma patients. No detectable levels of this antigen could be observed in pleural effusions of patients with cancers other than of breast origin. The H23-related antigen was localized in the cytoplasm of breast tumor cells as well as on the cell surface of both T47D cells and metastatic cells from breast cancer patients. A survey of tissue from 812 patients was performed by using H23 in an indirect immunoperoxidase assay. The results showed that the antigen was detectable in 91% of all breast tumors tested. No cytoplasmic staining was observed in either normal tissues or nonbreast carcinomas. Only one of the benign breast tissues tested (out of a total of 56 samples of tissue) was positive for this antigen. Given the ability of this antibody to specifically detect breast tumor cells, H23 may be of importance in diagnosis and in clinical follow-up of patients for the detection of metastatic lesions by imaging and for therapy.

Documentos Relacionados

• Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens.
• Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen.
• Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.
• Purification of Hodgkin's Disease Tumor-Associated Antigens
• Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens.